Nature outlook examines fight against malaria in Uganda

Nature Outlook examines the fight against malaria in Uganda. "Uganda's tragic failure to abate malaria has numerous political, geographic, economic and social factors -- and illustrates the reality that it takes more than scientific breakthroughs and cheap drugs to solve this persistent menace," according to the article. Nature describes how a primarily rural population, "[f]unding bottlenecks, inefficient procurement processes, transportation problems," drug stock-outs, and a lack of health care workers affects access to care and treatment for malaria, as well as how aid from the Global Fund to Fight AIDS, Tuberculosis, and Malaria, the Bill & Melinda Gates Foundation, the President's Malaria Initiative, and other donors is supporting programs to build sustainable solutions to fighting the disease (Newmen, 4/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug MED6-189 shows promise against drug-resistant malaria